Abstract
The present article highlights diverse roles of stem cells in healthy state, oncology and regenerative medicine in comparison to the Clear Cell Renal Cell Carcinoma (ccRCC) “stem cells”. Furthermore, we support the notion of urgent need to change the terminology of “cancer stem cells” into tumor-propagating cells (TPCs), and to diversify terms of kidney stem and kidney progenitor cell. We present the role of normal stem and progenitor cells in kidney development and regeneration in comparison to their markers. Moreover, we would like to introduce a hypothesis about the TPCs origin, and the role epithelial to mesenchymal transition in metastasis. We described current knowledge about various approaches to identification of renal TPCs. Finally, we present future perspectives in respect to current studies.
Keywords: Cancer stem cells, ccRCC, stem cells, tumor-propagating cells.
Current Signal Transduction Therapy
Title:Clear Cell Renal Cell Cancer Tumor-Propagating Cells: Molecular Characteristics
Volume: 8 Issue: 3
Author(s): Damian Matak, Lukasz Szymanski, Anna Czarnecka, Ewa Bartnik and Cezary Szczylik
Affiliation:
Keywords: Cancer stem cells, ccRCC, stem cells, tumor-propagating cells.
Abstract: The present article highlights diverse roles of stem cells in healthy state, oncology and regenerative medicine in comparison to the Clear Cell Renal Cell Carcinoma (ccRCC) “stem cells”. Furthermore, we support the notion of urgent need to change the terminology of “cancer stem cells” into tumor-propagating cells (TPCs), and to diversify terms of kidney stem and kidney progenitor cell. We present the role of normal stem and progenitor cells in kidney development and regeneration in comparison to their markers. Moreover, we would like to introduce a hypothesis about the TPCs origin, and the role epithelial to mesenchymal transition in metastasis. We described current knowledge about various approaches to identification of renal TPCs. Finally, we present future perspectives in respect to current studies.
Export Options
About this article
Cite this article as:
Matak Damian, Szymanski Lukasz, Czarnecka Anna, Bartnik Ewa and Szczylik Cezary, Clear Cell Renal Cell Cancer Tumor-Propagating Cells: Molecular Characteristics, Current Signal Transduction Therapy 2013; 8 (3) . https://dx.doi.org/10.2174/1574362409666140206222607
DOI https://dx.doi.org/10.2174/1574362409666140206222607 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Analytical and Pharmacological Aspects of Therapeutic Drug Monitoring of mTOR Inhibitors
Current Drug Metabolism Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System?
Current Pharmaceutical Design Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals
Recent Patents on Anti-Cancer Drug Discovery Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Peptides for Tumour Therapy and Diagnosis: Current Status and Future Directions
Current Medicinal Chemistry Bortezomib in the Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery Natural Compounds Therapeutic Features in Brain Disorders by Experimental, Bioinformatics and Cheminformatics Methods
Current Medicinal Chemistry Targeted Drug Delivery to Cancer Stem Cells through Nanotechnological Approaches
Current Stem Cell Research & Therapy Regulation of HIF-1α at the Transcriptional Level
Current Pharmaceutical Design Thioredoxin, Glutathione and Related Molecules in Tumors of the Nervous System
Current Medicinal Chemistry PI3K/ Akt/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence
Current Drug Targets Potential Targets for Improving Radiosensitivity of Breast Tumor-Initiating Cells
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Pretargeted Radioimmunotherapy
Current Medicinal Chemistry Recent Development of Peptide Drugs and Advance on Theory and Methodology of Peptide Inhibitor Design
Medicinal Chemistry Biotin-Encoded and Fe<sub>3</sub>O<sub>4</sub>-Loaded Polymeric Nano Micelles: Preparation, Optimization and In Vitro Characterization
Letters in Drug Design & Discovery Adhesion Molecules as Targets for the Treatment of Neoplastic Diseases
Current Pharmaceutical Design Microemulsions for Colorectal Cancer Treatments. General Considerations and Formulation of Methotrexate
Mini-Reviews in Medicinal Chemistry Protein Extracts from Somaclonal Mistletoe (Viscum Album L.) Callus with Increased Tumor Cytotoxic Activity in Vitro
Current Bioactive Compounds MicroRNA-21 as a Novel Therapeutic Target
Current Cancer Therapy Reviews p42.3 in Gastric Carcinoma: A Novel Biomarker and Promising Therapeutic Target
Letters in Drug Design & Discovery